+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Forecast 2024-2030- Product Image
Global Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Forecast 2024-2030- Product Image
Sale

Global Transplant Diagnostics Market by Offering (Instruments, Reagents & Consumables, Software & Services), Technology (Molecular Assays, Non-Molecular Assays), Transplant, Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986098
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transplant Diagnostics Market size was estimated at USD 4.59 billion in 2023, USD 4.91 billion in 2024, and is expected to grow at a CAGR of 7.55% to reach USD 7.65 billion by 2030.

Transplant diagnostics are tests to check the compatibility between the donor and recipient of an organ before or after transplant to reduce the risk of organ rejection and improve the success rate of transplants. Transplant diagnostics tests are used in various disciplines, such as immunogenetics, pathology, and infectious diseases. Transplant diagnostics also help improve transplant recipients' quality of life by providing more accurate and timely diagnosis and treatment. Increasing awareness of organ donation & transplant, increasing focus on research and development of transplant diagnostics, and rapid new technological development drive the market growth. However, the high cost of transplantation and treatment using advanced modalities and technology products may limit end users' adoption of transplant diagnostics. New technological advancements, regulatory guidelines for transplant diagnostics, and strategic initiatives by the market players are expected to create new opportunities for the market.

Regional Insights

The Americas is a significant market in transplant diagnostics due to growth in the geriatric population and the increase in infectious diseases. The new product development by key market players, financed organizations, infrastructure, and government participation in increasing funds and awareness to encourage the transplantation of organs for patients are the major factors for the market growth in the region. The rising investment in the medical sector from the private sector is also vital for the global transplant diagnostics market. The rise in transplant diagnostic surgeries, increasing demand from emerging markets, and expansion of healthcare industries are significant factors of the market adoption in the European market. Moreover, the Asia-Pacific transplant diagnostics market is expected to grow due to the rising number of organ donation camps and awareness programs across the region. Increasing adoption of technological development in transplant diagnostics is anticipated to boost the market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transplant Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transplant Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, altona Diagnostics GmbH, Arquer Diagnostics Ltd., BAG Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMérieux SA, Bruker Corporation, CareDx, Inc., CLONIT srl, Diagnóstica Longwood SL, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Genome Diagnostics B.V., Hologic, Inc., Illumina, Inc, Immucor, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Merck KGaA, NanoString Technologies, Inc., Novartis AG, PathoNostics B.V, QIAGEN, N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., TransMedics, Inc., and Zimmer Biomet Group.

Market Segmentation & Coverage

This research report categorizes the Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Instruments
    • Reagents & Consumables
    • Software & Services
  • Technology
    • Molecular Assays
    • Non-Molecular Assays
  • Transplant
    • Soft Tissue Transplant
    • Solid Organ Transplant
    • Stem Cell Transplant
  • Application
    • Diagnostic Applications
    • Research Applications
  • End User
    • Hospitals & Transplant Centers
    • Independent Reference Laboratories
    • Research Laboratories & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Transplant Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transplant Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Transplant Diagnostics Market?
  4. What is the market share of the leading vendors in the Transplant Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Transplant Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Transplant Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness for organ donation and rise in organ transplant
5.1.1.2. Increased focus on research & development of transplant diagnostics
5.1.1.3. Growing medical tourism in developing countries
5.1.2. Restraints
5.1.2.1. High cost associated with organ transplant procedures
5.1.3. Opportunities
5.1.3.1. Increasing technological advancements in transplant diagnostics
5.1.3.2. Growing regulatory guidelines for organ transplant
5.1.4. Challenges
5.1.4.1. Lack of insurance and reimbursement policies and complications of organ transplant
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Transplant Diagnostics Market, by Offering
6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Software & Services
7. Transplant Diagnostics Market, by Technology
7.1. Introduction
7.2. Molecular Assays
7.3. Non-Molecular Assays
8. Transplant Diagnostics Market, by Transplant
8.1. Introduction
8.2. Soft Tissue Transplant
8.3. Solid Organ Transplant
8.4. Stem Cell Transplant
9. Transplant Diagnostics Market, by Application
9.1. Introduction
9.2. Diagnostic Applications
9.3. Research Applications
10. Transplant Diagnostics Market, by End User
10.1. Introduction
10.2. Hospitals & Transplant Centers
10.3. Independent Reference Laboratories
10.4. Research Laboratories & Academic Institutes
11. Americas Transplant Diagnostics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Transplant Diagnostics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Transplant Diagnostics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Werfen to acquire transfusion and transplant diagnostics innovator for around USD 2 billion
14.3.1.2. Thermo Fisher will buy the binding site for $2.6B to gain specialty diagnostics portfolio
14.3.1.3. GenDx to develop NGS-Turbo following agreement with Oxford Nanopore Technologies
14.3.1.4. Eurobio Scientific buys Dutch transplant diagnostics firm GenDx for €135 million
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Immucor and Pirche announce multi-year partnership
14.3.3. New Product Launch & Enhancement
14.3.3.1. Quest Diagnostics unveils advanced transplant diagnostic services featuring anywhere-access in the United States
14.3.3.2. Eurofins Scientific SE: Transplant Genomics announces the launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimize immunosuppression in liver transplant recipients
14.3.3.3. Immucor announces innovations in transplant diagnostics
14.3.4. Award, Recognition, & Expansion
14.3.4.1. Plexision launches personalized transplant diagnostic testing in India
14.3.4.2. Eurofins Viracor opens expansive laboratory in Lenexa, KS
14.3.4.3. Hologic announces FDA approval of Aptima CMV Quant Assay For Human Cytomegalovirus
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Adaptive Biotechnologies Corporation
15.1.3. altona Diagnostics GmbH
15.1.4. Arquer Diagnostics Ltd.
15.1.5. BAG Group
15.1.6. Becton, Dickinson and Company
15.1.7. Bio-Rad Laboratories, Inc.
15.1.8. Biogenuix Medsystems Pvt. Ltd
15.1.9. BioMérieux SA
15.1.10. Bruker Corporation
15.1.11. CareDx, Inc.
15.1.12. CLONIT srl
15.1.13. Diagnóstica Longwood SL
15.1.14. DiaSorin S.p.A.
15.1.15. Eurofins Scientific SE
15.1.16. F. Hoffmann-La Roche Ltd.
15.1.17. Genome Diagnostics B.V.
15.1.18. Hologic, Inc.
15.1.19. Illumina, Inc
15.1.20. Immucor, Inc.
15.1.21. Laboratory Corporation of America Holdings
15.1.22. Luminex Corporation
15.1.23. Merck KGaA
15.1.24. NanoString Technologies, Inc.
15.1.25. Novartis AG
15.1.26. PathoNostics B.V
15.1.27. QIAGEN, N.V.
15.1.28. Quest Diagnostics Incorporated
15.1.29. Randox Laboratories Ltd.
15.1.30. Takara Bio Inc.
15.1.31. Thermo Fisher Scientific Inc.
15.1.32. TransMedics, Inc.
15.1.33. Zimmer Biomet Group
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
FIGURE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2030 (%)
FIGURE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 6. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 13. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFT TISSUE TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOLID ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STEM CELL TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY HOSPITALS & TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 40. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 42. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 45. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 67. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 69. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 72. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 74. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 82. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 112. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 128. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 133. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 138. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 143. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 148. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 158. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 160. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 173. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 178. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 180. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 183. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 185. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 203. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 218. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TRANSPLANT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 233. TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. TRANSPLANT DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • altona Diagnostics GmbH
  • Arquer Diagnostics Ltd.
  • BAG Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogenuix Medsystems Pvt. Ltd
  • BioMérieux SA
  • Bruker Corporation
  • CareDx, Inc.
  • CLONIT srl
  • Diagnóstica Longwood SL
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics B.V.
  • Hologic, Inc.
  • Illumina, Inc
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Merck KGaA
  • NanoString Technologies, Inc.
  • Novartis AG
  • PathoNostics B.V
  • QIAGEN, N.V.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransMedics, Inc.
  • Zimmer Biomet Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.91 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.65 Billion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Transplant Diagnostics Global Market Report 2024 - Product Image

Transplant Diagnostics Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Transplant Diagnostics - Global Strategic Business Report - Product Image

Transplant Diagnostics - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Serological Transplant Diagnostics - Global Strategic Business Report - Product Image

Serological Transplant Diagnostics - Global Strategic Business Report

  • Report
  • 161 Pages
  • Global
From
Serological Transplant Diagnostics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Serological Transplant Diagnostics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 100 Pages
  • Global
From
Transplant Diagnostic Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Transplant Diagnostic Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 78 Pages
  • Global
From

About the Market

The Transplant Diagnostics market is a subset of the Diagnostics industry, which focuses on the development and commercialization of tests and technologies used to diagnose and monitor transplant patients. These tests are used to detect and monitor the presence of donor-derived cells, as well as to assess the risk of rejection and other complications. Transplant Diagnostics also includes tests used to detect and monitor infections, such as viruses and bacteria, that can be transmitted through transplanted organs. The Transplant Diagnostics market is driven by the increasing number of organ transplants, as well as the need for improved patient outcomes. Additionally, the development of new technologies and tests, such as next-generation sequencing and mass spectrometry, has enabled more accurate and timely diagnosis and monitoring of transplant patients. Some companies in the Transplant Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Cepheid, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.